Preclinical murine tumor models: a structural and functional perspective

Preclinical murine tumor models: a structural and functional perspective

The goal of this review is to pinpoint the specific features, including the weaknesses, of various tumor models, and to discuss the reasons why treatments that are efficient in murine tumor models often do not work in clinics. In a detailed comparison of transplanted and spontaneous tumor models, we...

Bibliografiset tiedot
Päätekijät:	Guerin, MV, Finisguerra, V, Van den Eynde, BJ, Bercovici, N, Trautmann, T
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	eLife Sciences Publications, Ltd 2020

Samankaltaisia teoksia

Preclinical murine tumor models: A structural and functional perspective
Tekijä: Marion V Guerin, et al.
Julkaistu: (2020-01-01)

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells
Tekijä: Dvorakova, T, et al.
Julkaistu: (2024)

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
Tekijä: Finisguerra, V, et al.
Julkaistu: (2023)

The Remarkable Plasticity of Macrophages: A Chance to Fight Cancer
Tekijä: Nadège Bercovici, et al.
Julkaistu: (2019-07-01)

Arid5a: A missing link between EMT and tumoral immune resistance
Tekijä: Van den Eynde, BJ
Julkaistu: (2021)

TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors
Tekijä: Marion V. Guerin, et al.
Julkaistu: (2019-09-01)

Tryptophan 2,3-dioxygenase expression identified in murine decidual stromal cells is not essential for feto-maternal tolerance
Tekijä: Hoffmann, D, et al.
Julkaistu: (2020)

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells
Tekijä: Tereza Dvorakova, et al.
Julkaistu: (2024-09-01)

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
Tekijä: Benoit J Van den Eynde, et al.
Julkaistu: (2023-05-01)

Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse
Tekijä: Maxime Thoreau, et al.
Julkaistu: (2020-10-01)

Functional differences between proteasome subtypes
Tekijä: Abi Habib, J, et al.
Julkaistu: (2022)

Novel preclinical murine model of trauma-induced elbow stiffness
Tekijä: Stephanie N. Moore-Lotridge, et al.
Julkaistu: (2018-09-01)

Combining personalized neoantigen vaccination with chemotherapy and anti-PD-1 to treat NSCLC
Tekijä: Leung, CSK, et al.
Julkaistu: (2022)

Tryptophan-degrading enzymes in tumoral immune resistance
Tekijä: Nicolas van Baren, et al.
Julkaistu: (2016-11-01)

Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance
Tekijä: Delia Hoffmann, et al.
Julkaistu: (2020-12-01)

TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism
Tekijä: Canè, S, et al.
Julkaistu: (2021)

Combining Photodynamic Therapy with Immunostimulatory Nanoparticles Elicits Effective Anti-Tumor Immune Responses in Preclinical Murine Models
Tekijä: Ruben Victor Huis in ‘t Veld, et al.
Julkaistu: (2021-09-01)

Circulating tumor cell-derived preclinical models: current status and future perspectives
Tekijä: Zuzana Kahounová, et al.
Julkaistu: (2023-08-01)

The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
Tekijä: Julia M. Weiss, et al.
Julkaistu: (2017-10-01)

Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance
Tekijä: Hennequart, M, et al.
Julkaistu: (2017)

A Novel Preclinical Murine Model of Systemic Lupus Erythematosus–Like Cardiovascular Disease
Tekijä: Marice K. McCrorey, et al.
Julkaistu: (2024-12-01)

Editorial: Heme proteins: key players in the regulation of immune responses
Tekijä: Volpi, C, et al.
Julkaistu: (2023)

Uncovering molecular actors of IDO-mediated T cell dysfunction with genome-wide CRISPR/Cas9 knockout screens
Tekijä: Bombart, R, et al.
Julkaistu: (2022)

A 31-plex panel for high-dimensional single-cell analysis of murine preclinical models of solid tumors by imaging mass cytometry
Tekijä: Yaël Glasson, et al.
Julkaistu: (2023-01-01)

Correction: Circulating tumor cell-derived preclinical models: current status and future perspectives
Tekijä: Zuzana Kahounová, et al.
Julkaistu: (2024-07-01)

Systemic tryptophan homeostasis
Tekijä: Klaessens, S, et al.
Julkaistu: (2022)

MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes.
Tekijä: Broom, K, et al.
Julkaistu: (2007)

Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
Tekijä: Zhu, J, et al.
Julkaistu: (2018)

Secondary Ischemia Assessment in Murine and Rat Preclinical Subarachnoid Hemorrhage Models: A Systematic Review
Tekijä: Elias Fürstenau, et al.
Julkaistu: (2024-03-01)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
Tekijä: Demuytere J, et al.
Julkaistu: (2024-01-01)

MRI and MRS alterations in the preclinical phase of murine prion disease: Association with neuropathological and behavioural changes
Tekijä: Kerry A. Broom, et al.
Julkaistu: (2007-06-01)

Editorial: Inhibitors of CDK family: New perspective and rationale for drug combination in preclinical models of solid tumors
Tekijä: Andrea Cavazzoni, et al.
Julkaistu: (2023-03-01)

Characterization of retinal function and structure in the MPTP murine model of Parkinson’s disease
Tekijä: Katie K. N. Tran, et al.
Julkaistu: (2022-05-01)

Preclinical Models of Pediatric Brain Tumors—Forging Ahead
Tekijä: Tara H.W. Dobson, et al.
Julkaistu: (2018-10-01)

Preclinical Ward Teaching Student's Perspective
Tekijä: Tehreem Fatima, et al.
Julkaistu: (2014-06-01)

Trophic and immunomodulatory effects of adipose tissue derived stem cells in a preclinical murine model of endometriosis
Tekijä: Toyofumi Hirakawa, et al.
Julkaistu: (2022-05-01)

In Vivo Murine-Matured Human CD3+ Cells as a Preclinical Model for T Cell-Based Immunotherapies
Tekijä: Kevin G. Haworth, et al.
Julkaistu: (2017-09-01)

Preclinical Evaluation of Anti-HIV-1 Polybiguanide Vaginal Microbicides in a Murine Model of Toxicity and Inflammation
Tekijä: Krebs Fred C, et al.
Julkaistu: (2005-12-01)

Blood–Brain Barrier Dysfunction in Mild Traumatic Brain Injury: Evidence From Preclinical Murine Models
Tekijä: Yingxi Wu, et al.
Julkaistu: (2020-08-01)

Photoacoustic-based oxygen saturation assessment of murine femoral bone marrow in a preclinical model of leukemia
Tekijä: Cayla Wood, et al.
Julkaistu: (2019-06-01)